Package 82511-002-50

Brand: capecitabine

Generic: capecitabine
NDC Package

Package Facts

Identity

Package NDC 82511-002-50
Digits Only 8251100250
Product NDC 82511-002
Product ID 82511-002_2b3f98b5-d81c-d87d-e063-6294a90a7e87
Description

120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82511-002-50)

Marketing

Marketing Status
Marketed Since 2022-02-16
Brand capecitabine
Generic capecitabine
Sample Package No

Linked Drug Pages (1)

Capecitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2b3f98b5-d81c-d87d-e063-6294a90a7e87", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["6804DJ8Z9U"], "rxcui": ["200327", "200328"], "spl_set_id": ["0c873e5b-51c2-4685-86c5-53f98563b093"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Teyro Labs Private Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82511-002-50)", "package_ndc": "82511-002-50", "marketing_start_date": "20220216"}], "brand_name": "Capecitabine", "product_id": "82511-002_2b3f98b5-d81c-d87d-e063-6294a90a7e87", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "82511-002", "generic_name": "capecitabine", "labeler_name": "Teyro Labs Private Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Capecitabine", "active_ingredients": [{"name": "CAPECITABINE", "strength": "500 mg/1"}], "application_number": "ANDA217237", "marketing_category": "ANDA", "marketing_start_date": "20220216", "listing_expiration_date": "20261231"}